Renal cancer cells lacking hypoxia inducible factor (HIF)-1  expression maintain vascular endothelial growth factor expression through HIF-2 

Toshiaki Shinojima, Mototsugu Oya, Atsushi Takayanagi, +3

Carcinogenesis

Profiling the inhibitory receptors LAG-3, TIM-3, and TIGIT in renal cell carcinoma reveals malignancy

Kimiharu Takamatsu, Nobuyuki Tanaka, Kyohei Hakozaki, +21

Nature Communications

Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer

Tsukasa Masuda, Nobuyuki Tanaka, Kimiharu Takamatsu, +13

Journal for ImmunoTherapy of Cancer

High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel Chemotherapy

Keisuke Shigeta, Takeo Kosaka, Shigehisa Kitano, +9

Annals of Surgical Oncology

UrologyDocetaxel ChemotherapyGenitourinary CancerMedicinePharmacotherapy +6

Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer

Yujiro Ito, Eiji Kikuchi, Nobuyuki Tanaka, +7

BMC Cancer

Prognostic significance of grade 3/4 neutropenia in Japanese prostate cancer patients treated with cabazitaxel

Takeo Kosaka, Toshiaki Shinojima, Shinya Morita, +1

Cancer Science

Activation of aryl hydrocarbon receptor promotes invasion of clear cell renal cell carcinoma and is associated with poor prognosis and cigarette smoke

Masaru Ishida, Shuji Mikami, Toshiaki Shinojima, +6

International Journal of Cancer

UrologyOncogenic AgentKidney ResearchAryl Hydrocarbon ReceptorImmunology +11

Decreased Acetylation of Histone H3 in Renal Cell Carcinoma: A Potential Target of Histone Deacetylase Inhibitors

Kent Kanao, Shuji Mikami, Ryuichi Mizuno, +3

The Journal of Urology

Multiplexed single-cell pathology reveals the association of CD8 T-cell heterogeneity with prognostic outcomes in renal cell carcinoma

Tetsushi Murakami, Nobuyuki Tanaka, Kimiharu Takamatsu, +11

Cancer Immunology Immunotherapy

Tumor BiologyUrologyCancer ImmunosurveillanceCd8 T-cell HeterogeneityGenitourinary Cancer +10

Establishment of the optimal follow-up schedule after radical prostatectomy

Kazuhiro Matsumoto, Naoya Niwa, Seiya Hattori, +8

Urologic Oncology Seminars and Original Investigations

UrologySurgical OncologyRadical ProstatectomyTreatment PlanningOutcomes Research +3